Insider Selling: Omada Health (NASDAQ:OMDA) CFO Sells $378,206.50 in Stock

Omada Health, Inc. (NASDAQ:OMDA) CFO Steven Cook sold 17,950 shares of the stock in a transaction on Monday, June 29th. The shares were sold at an average price of $21.07, for a total transaction of $378,206.50. Following the transaction, the chief financial officer directly owned 115,409 shares in the company, valued at approximately $2,431,667.63. This represents a 13.46% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link.

Omada Health Stock Down 1.0%

Omada Health stock opened at $22.39 on Friday. The firm has a fifty day simple moving average of $17.16 and a two-hundred day simple moving average of $15.03. Omada Health, Inc. has a twelve month low of $10.28 and a twelve month high of $26.92. The company has a market capitalization of $1.33 billion and a PE ratio of -82.93.

Omada Health (NASDAQ:OMDA) last announced its quarterly earnings data on Thursday, May 7th. The company reported ($0.05) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.08) by $0.03. The firm had revenue of $78.05 million for the quarter. Omada Health had a negative return on equity of 1.82% and a negative net margin of 2.22%. As a group, equities analysts expect that Omada Health, Inc. will post -0.01 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several research analysts have recently issued reports on the stock. Weiss Ratings upgraded shares of Omada Health from a “sell (e+)” rating to a “sell (d-)” rating in a report on Friday, June 26th. Morgan Stanley reissued an “overweight” rating and set a $30.00 price target on shares of Omada Health in a research report on Monday, June 22nd. Wall Street Zen raised shares of Omada Health from a “hold” rating to a “buy” rating in a report on Saturday, June 27th. JPMorgan Chase & Co. decreased their price objective on shares of Omada Health from $32.00 to $26.00 and set an “overweight” rating on the stock in a research report on Thursday, March 12th. Finally, Barclays upped their price objective on shares of Omada Health from $18.00 to $20.00 and gave the company an “overweight” rating in a research note on Friday, May 8th. Ten equities research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, Omada Health currently has an average rating of “Moderate Buy” and a consensus target price of $22.91.

Hedge Funds Weigh In On Omada Health

Several hedge funds have recently made changes to their positions in OMDA. Raymond James Financial Inc. purchased a new stake in Omada Health in the second quarter worth $32,000. Quarry LP purchased a new position in Omada Health during the 4th quarter valued at $29,000. TD Waterhouse Canada Inc. bought a new position in Omada Health in the 4th quarter worth $32,000. Inlight Wealth Management LLC bought a new position in Omada Health in the 4th quarter worth $45,000. Finally, Versant Capital Management Inc lifted its position in shares of Omada Health by 319.3% in the 2nd quarter. Versant Capital Management Inc now owns 2,998 shares of the company’s stock worth $66,000 after purchasing an additional 2,283 shares during the period.

Omada Health Company Profile

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.